English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT
康哲藥業(867.HK/8A8.SG):創新藥磷酸蘆可替尼乳膏增加特應性皮炎(AD)適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT
康哲药业(867.HK/8A8.SG):创新药磷酸芦可替尼乳膏增加特应性皮炎(AD)适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 24, 2026 18:22 HKT
康希諾生物曼海欣(R)擴齡正式獲批 為公司長期價值開啟更廣闊發展空間
Feb 24, 2026 18:15 HKT
康希诺生物曼海欣(R)扩龄正式获批 为公司长期价值开启更广阔发展空间
Feb 24, 2026 18:08 HKT
滬港新興產業基石基金在港正式開業
Feb 24, 2026 12:48 HKT
沪港新兴产业基石基金在港正式开业
Feb 24, 2026 12:27 HKT
維昇藥業(2561.HK)維臻高(R)獲批:重長效生長激素王者登場 重構百億市場的商業天花板
Feb 24, 2026 10:43 HKT
维昇药业(2561.HK)维臻高(R)获批:重长效生长激素王者登场 重构百亿市场的商业天花板
Feb 24, 2026 10:12 HKT
Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus
Feb 23, 2026 20:00 HKT
現代牙科集團四十週年誌慶:「數字驅動 重塑笑容新標準」
Feb 13, 2026 10:36 HKT
Modern Dental Group Celebrates 40 Years: 'Redefining Smiles. The Digital Way.'
Feb 13, 2026 10:31 HKT
现代牙科集团四十周年志庆:「数字驱动 重塑笑容新标准」
Feb 13, 2026 09:40 HKT
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Feb 11, 2026 19:00 HKT
愛芯元智上市 聯控(3396.HK)旗下聯想之星開年收穫3個IPO
Feb 11, 2026 18:07 HKT
爱芯元智上市 联控(3396.HK)旗下联想之星开年收获3个IPO
Feb 11, 2026 17:48 HKT
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong
Feb 10, 2026 18:14 HKT
億勝生物參展香港2026年亞太眼科學會年會(APAO 2026)强化眼科創新承諾
Feb 10, 2026 17:52 HKT
亿胜生物参展香港2026年亚太眼科学会年会(APAO 2026)强化眼科创新承诺
Feb 10, 2026 17:32 HKT
Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: